Life/Health Medical Consultant, Shanghai
Ning Qing joined Gen Re in 2020 and has more than 15 years of experience. Ning is responsible for medical research and claims in mainland China. Her primary focus is the analysis of Critical Illness products.
With a compound annual insurance premium growth rate of over 30% for six consecutive years, RMB817.3 billion-worth of premium recorded for 2020 and RMB2 trillion anticipated for 2025, the health insurance market in China continues to outpace all other...Erfahren Sie mehr